| P2093 | author name string | Zambon MC | |
| | Watson JM | |
| | Dedman D | |
| | Laurichesse H | |
| P2860 | cites work | A respiratory outbreak due to parainfluenza virus type 3 in a home for the aged--Ontario. | Q45785732 |
| | A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and Children | Q45788311 |
| | Natural history of parainfluenza virus infection in childhood | Q45800145 |
| | Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population | Q45823296 |
| | Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine | Q45823297 |
| | Respiratory syncytial virus and parainfluenza virus surveillance--United States, 1989-90. | Q45850699 |
| | Studies on the epidemiology of child infections. 3. Parainfluenza viruses (types 1-4) and respiratory syncytial virus infections | Q45876117 |
| | Rapid identification of respiratory viruses: impact on isolation practices and transmission among immunocompromised pediatric patients | Q50194239 |
| | Paramyxovirus infection in lung transplant recipients | Q50589149 |
| | Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. | Q53632367 |
| | Croup: an 11-year study in a pediatric practice | Q67297886 |
| | Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period | Q68656827 |
| | Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics | Q72072054 |
| | Newly recognized myxoviruses from children with respiratory disease | Q74791885 |
| | Acute respiratory diseases of viral etiology. III. parainfluenza. Myxoviruses | Q76493115 |
| | Biology of parainfluenza viruses | Q24615805 |
| | Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study | Q29615116 |
| | Orthomyxoviral and paramyxoviral infections in transplant patients. | Q30468828 |
| | Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit | Q33676173 |
| | Respiratory viral infections in immunocompetent and immunocompromised persons | Q33950796 |
| | Community respiratory virus infections in immunocompromised patients with cancer | Q33950804 |
| | Community respiratory viruses in individuals with human immunodeficiency virus infection | Q33950811 |
| | Community respiratory viruses: organ transplant recipients | Q33950817 |
| | Infection control of nosocomial respiratory viral disease in the immunocompromised host | Q33950831 |
| | Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients | Q33950838 |
| | Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children | Q34333040 |
| | Association of a new type of cytopathogenic myxovirus with infantile croup | Q36263100 |
| | Application of information technology to the laboratory reporting of communicable disease in England and Wales | Q36697504 |
| | Current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development: memorandum from a joint WHO/NIAID meeting | Q36795376 |
| | Parainfluenza virus respiratory infection after heart transplantation: successful treatment with ribavirin | Q38949301 |
| | Viral pulmonary infections in thoracic and cardiovascular surgery. | Q40445252 |
| | Meningitis due to parainfluenza virus type 3: report of two cases and review | Q40716388 |
| | Isolation of parainfluenza virus type 3 from cerebrospinal fluid associated with aseptic meningitis | Q40716865 |
| | Lower respiratory viral infections in immunocompetent children. | Q40722364 |
| | Parainfluenza Virus Respiratory Infection after Bone Marrow Transplantation | Q40734883 |
| | Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host | Q41007795 |
| | Food poisoning: notifications, laboratory reports, and outbreaks--where do the statistics come from and what do they mean? | Q41015619 |
| | Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats | Q41678091 |
| | Brief report: parainfluenza virus type 3 infections: findings in Sydney and some observations on variations in seasonality world-wide | Q42011809 |
| | Epidemiology of parainfluenza virus type 3 in England and Wales over a ten-year period | Q42588401 |
| | Studies of a new human hemadsorption virus. I. Isolation, properties and characterization. | Q43846948 |
| | Parainfluenza virus and neurologic signs. | Q43973665 |
| | Parainfluenza virus infection in adult bone marrow transplant recipients | Q44512888 |
| | Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children | Q44825036 |
| | Parainfluenza and influenza virus infections in pediatric organ transplant recipients. | Q44997995 |
| | Respiratory virus infections in bone marrow transplant recipients: the European perspective | Q45741856 |
| | Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience | Q45741859 |
| | Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics | Q45759130 |
| | Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. | Q45764064 |
| | Parainfluenza virus type 4 infections in pediatric patients | Q45765187 |
| | Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients | Q45766275 |
| | Molecular epidemiology of a parainfluenza type 3 virus outbreak on a pediatric ward | Q45775242 |
| | Infections due to parainfluenza virus type 4 in children | Q45779642 |
| | Parainfluenza virus type 2 meningitis and parotitis in an 11-year-old child | Q45784327 |
| | A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children | Q45785698 |
| P433 | issue | 5 | |
| P304 | page(s) | 475-484 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | European Journal of Epidemiology | Q5412723 |
| P1476 | title | Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997. | |
| P478 | volume | 15 | |